<DOC>
	<DOCNO>NCT01402076</DOCNO>
	<brief_summary>The purpose research study understand whether difference amount midazolam ( include breakdown product ) blood midazolam give tasimelteon , whether difference amount rosiglitazone blood rosiglitazone give tasimelteon .</brief_summary>
	<brief_title>A Study Assess Effect Tasimelteon Cytochrome P450 3A4 2C8 Enzymes Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>1 . Ability acceptance provide write informed consent ; 2 . Subjects must males female 18 55 year age , inclusive ; 3 . Female subject childbearing potential must nonpregnant nonlactating negative serum urine pregnancy test Screening visit Checkin ( Days 1 ) agree attempt become pregnant course study . Female subject childbearing potential ( include perimenopausal woman menstrual bleeding within 1 year ) must use appropriate birth control ( e.g . intrauterine device [ IUD ] , diaphragm condom spermicidal jelly foam abstinence , cervical cap ) period 35 day first dose , duration study , one month last dose ; . Note : Women permit use hormonal method birth control ( e.g . oral contraceptive , hormonal intrauterine device [ IUD ] , patch steroid ) must use another acceptable method birth control study one month last dose . Women currently take oral contraceptive require discontinue regimen two week prior first dose . 4 . Subjects Body Mass Index ( BMI ) &gt; 18 &lt; 35 kg/m2 ( BMI = weight ( kg ) / [ height ( ) ] 2 ) ; 5 . Vital sign ( 3 minute rest semisupine position ) within range show : 1 . Body temperature 35.037.5 Â°C ; 2 . Systolic blood pressure 90150 mm Hg ; 3 . Diastolic blood pressure 5095 mm Hg ; 4 . Pulse rate 50100 bpm . 6 . Willing able comply study requirement ; 7 . Subjects must good health determine past medical history , physical examination , electrocardiogram , clinical laboratory test urinalysis ; 1 . History recent ( within six month ) drug alcohol abuse ; 2 . Any major surgery within three month Day 1 minor surgery within one month ; 3 . Donation loss 400 mL blood within two month prior Baseline Visit ; 4 . History current evidence cardiovascular , hepatic , hematopoietic , renal , gastrointestinal metabolic dysfunction judge Investigator clinically significant ; 5 . Any condition require regular use medication ; 6 . History intolerance and/or hypersensitivity drug include midazolam , rosiglitazone 'glitazones ' , melatonin melatonin agonist , anyone take melatonin preparation chronically within past two month prior Day 1 ; 7 . History current evidence hypoglycemia judge Investigator clinically significant ; 8 . History liver disease and/or positive one follow serological result : HCV , HIV , HBsAg 9 . Treatment drug know cause major organ system toxicity ( e.g. , chloramphenicol tamoxifen ) 60 day precede Day 1 ; 10 . Elevated ( &gt; 2 time upper limit normal ) liver function test ( i.e . aspartate aminotransferase ( AST [ SGOT ] ) , alanine aminotransferase ( ALT [ SGPT ] ) , total bilirubin ) ; 11 . Inability venipunctured and/or tolerate venous access ; 12 . Subjects use tobacco product 3 month prior dose . 13 . Exposure investigational drug within 30 day 5 half life ( whichever longer ) baseline , include placebo ; 14 . Participation previous BMS214778/VEC162 trial ; 15 . Use prescription OTC medication , include herbal product ( e.g. , St. John 's Wort ) within 2 week Day 1 ; 16 . Use food beverage contain alcohol , grapefruit grapefruit juice , apple orange juice , vegetables mustard green family ( e.g . kale , broccoli , watercress , collard green , kohlrabi , brussel sprout , mustard ) charbroiled meat within 1 week Day 1 actual duration study ; 17 . Any sound medical reason determine clinical Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Drug Interaction</keyword>
</DOC>